For people at risk of getting seriously ill from Covid-19, the antiviral drug Paxlovid can be a game-changer. But a leading GP says roughly 30% of New Zealanders eligible are turning down antivirals. It would later be known as Paxlovid – and has since emerged as the country’s preferred Covid-19 antiviral. And while barriers to access have emerged, there is a wedge of people who are turning antivirals down. Supplied Boxes of Paxlovid antivirals for Covid-19.
